ToplineOn Saturday, the FDA granted Emergency Use Authorization to Johnson & Johnson’s single-dose Covid-19 vaccine, meaning that it will soon be publicly available in the U.SA healthcare worker fills a syringe from a vial with a dose of the Johnson & Johnson vaccine against ... [+] the COVID-19 coronavirus in South Africa. This is now the third Covid-19 vaccine that has been granted Emergency Use Authorization, following the Moderna and Pfizer/BioNTech Covid-19 vaccines last year. Key BackgroundJohnson & Johnson submitted data to the FDA showing that its vaccine is about 66% effective at preventing moderate to severe Covid-19 vaccine. While the Johnson & Johnson vaccine is less effective at preventing symptomatic disease, it has several benefits over its competitors. Further ReadingEverything You Need To Know About Johnson & Johnson’s Covid-19 Vaccine (Forbes)How The Johnson & Johnson Vaccine Works (New York Times)Full coverage and live updates on the Coronavirus

Source: Forbes February 27, 2021 23:15 UTC